CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Nifedipine Sustained-release Tablets

Product Description

Tablets,Sustained-release,Controlled-Release

Beijing Lunarsun Pharmaceutical Co., Ltd.

Country/Region:

China
On CPHI since:

2015

Company types

Manufacturer/Innovator

Compare Add to favorites Added to favorites

Specifications

CAS Registry Number

21829-25-4
Details

Nifedipine Sustained-release Tablets(II):20mg;Nifedipine Sustained-release Tablets(I):10mg;Nifedipine Controlled-Release tablets:30mg
Selling Points
Our professional team provides technical guidance and high-quality service throughout the process
Model

Finished Dosage Form
Supplied from

China